Trial Outcomes & Findings for Protocolized Post-Extubation Respiratory Support Study (NCT NCT03288311)

NCT ID: NCT03288311

Last Updated: 2023-12-29

Results Overview

Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

751 participants

Primary outcome timeframe

within 96 hours of extubation

Results posted on

2023-12-29

Participant Flow

Participant milestones

Participant milestones
Measure
Protocolized Post-extubation Respiratory Support
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Overall Study
STARTED
359
392
Overall Study
COMPLETED
359
392
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Protocolized Post-Extubation Respiratory Support Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Total
n=751 Participants
Total of all reporting groups
Age, Continuous
56 years
n=5 Participants
57 years
n=7 Participants
57 years
n=5 Participants
Sex: Female, Male
Female
155 Participants
n=5 Participants
187 Participants
n=7 Participants
342 Participants
n=5 Participants
Sex: Female, Male
Male
204 Participants
n=5 Participants
205 Participants
n=7 Participants
409 Participants
n=5 Participants
Race/Ethnicity, Customized
White
287 Participants
n=5 Participants
317 Participants
n=7 Participants
604 Participants
n=5 Participants
Race/Ethnicity, Customized
Black or African American
58 Participants
n=5 Participants
59 Participants
n=7 Participants
117 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
3 Participants
n=5 Participants
8 Participants
n=7 Participants
11 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Race/Ethnicity, Customized
Not Reported
6 Participants
n=5 Participants
4 Participants
n=7 Participants
10 Participants
n=5 Participants

PRIMARY outcome

Timeframe: within 96 hours of extubation

Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Reintubation
57 Participants
52 Participants

SECONDARY outcome

Timeframe: from extubation to discharge or 28 days post-extubation

All cause mortality, censored at the first of hospital discharge or 28 days after extubation

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
All-cause In-hospital Death
29 Participants
41 Participants

SECONDARY outcome

Timeframe: from extubation to discharge or 28 days post-extubation

number of days alive from final ICU transfer until study day 28

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
ICU-free Days
26 days
Interval 23.0 to 26.0
26 days
Interval 22.0 to 26.0

SECONDARY outcome

Timeframe: from extubation to discharge or 28 days post-extubation

number of days alive from final invasive mechanical ventilation until study day 28

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Ventilator-free Days
28 days
Interval 28.0 to 28.0
28 days
Interval 28.0 to 28.0

SECONDARY outcome

Timeframe: from extubation to discharge or 28 days post-extubation

Time from extubation to reintubation

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Time to Reintubation
56 hours
Interval 21.0 to 147.0
47 hours
Interval 18.0 to 163.0

SECONDARY outcome

Timeframe: within 96 hours of extubation

Population: Full trial population

Number of patients in each group with respiratory indication for reintubation.

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Number of Patients Requiring Re-intubation for Respiratory Indication
35 Participants
33 Participants

SECONDARY outcome

Timeframe: within 96 hours of extubation

Percentage of patients in each group with laryngeal edema as the indication for reintubation

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Number of Patients Requiring Reintubation for Laryngeal Edema
0 Participants
2 Participants

SECONDARY outcome

Timeframe: within 96 hours of extubation

As defined by Confusion Assessment Method for the ICU (CAM-ICU) score and reported by bedside nurse. A report of "Yes" indicates the presence of delirium, which is reflected in the reported cases.

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Number of Patients With Delirium
160 Participants
151 Participants

SECONDARY outcome

Timeframe: within 96 hours of extubation

Population: Data was unavailable for collection

As defined by RAS score and reported by bedside nurse

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation

Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Lowest S/F Ratio
0-6 hours
237.5 ratio of O2 saturation to concentration
Interval 205.0 to 254.3
268.5 ratio of O2 saturation to concentration
Interval 224.4 to 344.4
Lowest S/F Ratio
6-12 hours
242.5 ratio of O2 saturation to concentration
Interval 222.5 to 303.3
318.5 ratio of O2 saturation to concentration
Interval 240.0 to 438.1
Lowest S/F Ratio
12-24 hours
242.5 ratio of O2 saturation to concentration
Interval 214.6 to 340.7
327.6 ratio of O2 saturation to concentration
Interval 240.0 to 438.1

SECONDARY outcome

Timeframe: between 0-6 hours, 6-12 hours, and 12-24 hours after extubation

Highest respiratory rate

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Highest Respiratory Rate
0-6 hours
23 breaths per minute
Interval 20.0 to 28.0
24 breaths per minute
Interval 21.0 to 28.0
Highest Respiratory Rate
6-12 hours
24 breaths per minute
Interval 19.0 to 28.0
24 breaths per minute
Interval 20.0 to 29.0
Highest Respiratory Rate
12-24 hours
25 breaths per minute
Interval 21.0 to 30.0
25 breaths per minute
Interval 21.0 to 29.0

SECONDARY outcome

Timeframe: from 24 hours post extubation to 96 hours post-extubation

Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation

Outcome measures

Outcome measures
Measure
Protocolized Post-extubation Respiratory Support
n=359 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning Protocolized post-extubation respiratory support: Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
Usual Care
n=392 Participants
Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Usual Care: Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team.
Use of High Flow Nasal Cannula (HFNC) or Non-invasive Ventilation (NIV) Beyond 24 Hours Post-extubation
26 Participants
14 Participants

Adverse Events

Protocolized Post-extubation Respiratory Support

Serious events: 0 serious events
Other events: 0 other events
Deaths: 29 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 41 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jonathan Casey, Assistant Professor of Medicine

Vanderbilt University Medical Center

Phone: 6158754681

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place